ArticleThoracic cancer2016

Retrospective study of adjuvant icotinib in postoperative lung cancer patients harboring epidermal growth factor receptor mutations.

Shuyang Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.